CrossComm, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain (NCT04838925) | CrossComm, Inc. | 2022-06-22 |
Track CrossComm, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.